EPISODE · Aug 23, 2026 · 5 MIN
Brazil ANVISA Innovative Device Pilot Program 2026: A Guide for High-Risk MedTech
from Medical Device Global Market Access
Brazil's ANVISA has opened a new pathway for innovative, high-risk medical devices. On August 5, 2026, the agency published Call Notice 5/2026, inviting manufacturers of Class III and IV devices with novel technologies to apply for a collaborative regulatory evaluation pilot program. This episode details the program's objectives, strict eligibility criteria (including AI-based devices and new biomaterials), the critical 30-day application window, and the strategic advantages of early engagement with ANVISA for accelerating market access in Brazil. Key Questions: - What is ANVISA's innovative medical device pilot program announced in August 2026? - Which types of high-risk medical devices are eligible to apply? - What are the specific eligibility criteria, such as the use of AI or new biomaterials? - What is the application deadline for Call Notice 5/2026? - How does this pilot program differ from the standard ANVISA review process? - What are the strategic benefits of participating in this collaborative evaluation? - What documentation is required for the application? - How can manufacturers prepare for this opportunity to accelerate market access in Brazil? Sources: - https://www.gov.br/anvisa/pt-br/assuntos/noticias/2026/anvisa-lanca-novo-edital-para-avaliacao-regulatoria-de-dispositivos-medicos-inovadores - https://www.sobel.com/innovative-medical-devices-in-brazil-how-anvisas-2026-pilot-program-works/ - https://www.demarest.com.br/en/insights/client-alerts/opportunity-anvisa-to-select-innovative-medical-device-projects-for-regulatory-assessment How Pure Global can help: Pure Global streamlines global market access for MedTech and IVD companies. With local experts in Brazil, we can act as your official representative and guide your regulatory strategy for complex products, including submissions for specialized programs like ANVISA's innovative device pilot. Our AI-powered platform helps prepare technical dossiers efficiently, ensuring your submission is comprehensive and competitive. We manage the entire lifecycle, from initial strategy to post-market surveillance, helping you enter and thrive in over 30 markets. Visit us at https://pureglobal.com, contact us at [email protected], or explore our free AI tools and database at https://pureglobal.ai.
Embed this episode
NOW PLAYING
Brazil ANVISA Innovative Device Pilot Program 2026: A Guide for High-Risk MedTech
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.